0001415889-24-027467.txt : 20241121 0001415889-24-027467.hdr.sgml : 20241121 20241121190558 ACCESSION NUMBER: 0001415889-24-027467 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241119 FILED AS OF DATE: 20241121 DATE AS OF CHANGE: 20241121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VERRASTRO PAUL CENTRAL INDEX KEY: 0001869761 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40545 FILM NUMBER: 241485985 MAIL ADDRESS: STREET 1: 9201 W BROADWAY AVE STREET 2: #650 CITY: MINNEAPOLIS STATE: MN ZIP: 55445 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CVRx, Inc. CENTRAL INDEX KEY: 0001235912 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9201 WEST BROADWAY AVENUE STREET 2: SUITE 650 CITY: MINNEAPOLIS STATE: MN ZIP: 55445 BUSINESS PHONE: 7634162850 MAIL ADDRESS: STREET 1: 9201 WEST BROADWAY AVENUE STREET 2: SUITE 650 CITY: MINNEAPOLIS STATE: MN ZIP: 55445 FORMER COMPANY: FORMER CONFORMED NAME: CVRX INC DATE OF NAME CHANGE: 20030527 4 1 form4-11222024_121153.xml X0508 4 2024-11-19 0001235912 CVRx, Inc. CVRX 0001869761 VERRASTRO PAUL 9201 W BROADWAY AVE #650 MINNEAPOLIS MN 55445 false true false false CHIEF MKTG & STRAT OFFICER 0 Common Stock 2024-11-19 4 M 0 2500 5.141 A 3305 D Common Stock 2024-11-19 4 S 0 1430 13.5781 D 1875 D Common Stock 2024-11-21 4 G 0 1040 0 D 835 D Stock Option (right to buy) 5.141 2024-11-19 4 M 0 2500 0 D 2031-01-04 Common Stock 2500 73306 D Reflects the weighted average price of 1,430 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on November 19, 2024 with sale prices ranging from $13.525 to $13.64 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Vested as to 25% of the shares on January 4, 2022 and vests as to 1/48th of the shares each month thereafter. /s/ Amy C. Seidel, Attorney-in-Fact 2024-11-21